Alpha-methyldopa induces a naltrexone-insensitive antinociception and hypomotility in rats. 1990

P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
Rudolf Magnus Institute for Pharmacology, Medical Faculty, University of Utrecht, The Netherlands.

1. This study served to investigate whether endogenous opioid peptides play a role in the putative antinociceptive and the sedative actions of alpha-methyldopa. 2. In conscious normotensive rats, alpha-methyldopa induced hypotension, starting around 1 h and reaching a maximum 3-4 h after administration. Pretreatment with naltrexone resulted in an inhibition of alpha-methyldopa-induced hypotension. 3. alpha-Methyldopa dose-dependently increased hot plate latency which became evident after a 4 h lag period and reaching a maximum effect at 6 h. The antinociceptive effect of alpha-methyldopa was not affected by naltrexone. 4. In a small open field, alpha-methyldopa dose-dependently suppressed locomotion and sniffing behaviour. These effects of alpha-methyldopa were apparent 1 h after administration and were naltrexone-insensitive. 5. No changes in the level of beta-endorphin-like immunoreactivity in plasma and cerebrospinal fluid were observed after administration of alpha-methyldopa. 6. The results indicate that endogenous opioid peptides are involved in the hypotensive action of alpha-methyldopa but not in alpha-methyldopa-induced hypomotility and antinociception.

UI MeSH Term Description Entries
D008297 Male Males
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004723 Endorphins One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group. Endorphin

Related Publications

P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
November 2002, Acta pharmacologica Sinica,
P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
February 2004, Nutritional neuroscience,
P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
September 2011, Behavioural pharmacology,
P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
November 1963, The Journal of pharmacy and pharmacology,
P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
June 1987, Behavioral neuroscience,
P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
January 1999, Alcohol and alcoholism (Oxford, Oxfordshire),
P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
February 1984, The American journal of psychiatry,
P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
January 1977, Progress in brain research,
P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
December 2005, Behavioural pharmacology,
P L van Giersbergen, and E van Duinkerken, and C G Sweep, and V M Wiegant, and J M van Ree, and W de Jong
July 1963, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Copied contents to your clipboard!